Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS.

Kallio SP, Jakkula E, Purcell S, Suvela M, Koivisto K, Tienari PJ, Elovaara I, Pirttilä T, Reunanen M, Bronnikov D, Viander M, Meri S, Hillert J, Lundmark F, Harbo HF, Lorentzen AR, De Jager PL, Daly MJ, Hafler DA, Palotie A, Peltonen L, Saarela J.

Hum Mol Genet. 2009 May 1;18(9):1670-83. doi: 10.1093/hmg/ddp073. Epub 2009 Feb 16.

2.

Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.

Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, Søndergaard HB, Harbo HF, Mero IL, Gabriel SB, Mirel DB, Hauser SL, Kappos L, Polman C, De Jager PL, Hafler DA, Daly MJ, Palotie A, Saarela J, Peltonen L.

Am J Hum Genet. 2010 Feb 12;86(2):285-91. doi: 10.1016/j.ajhg.2010.01.017.

3.

Fine mapping of a multiple sclerosis locus to 2.5 Mb on chromosome 17q22-q24.

Saarela J, Schoenberg Fejzo M, Chen D, Finnilä S, Parkkonen M, Kuokkanen S, Sobel E, Tienari PJ, Sumelahti ML, Wikström J, Elovaara I, Koivisto K, Pirttilä T, Reunanen M, Palotie A, Peltonen L.

Hum Mol Genet. 2002 Sep 15;11(19):2257-67.

PMID:
12217954
4.

PRKCA and multiple sclerosis: association in two independent populations.

Saarela J, Kallio SP, Chen D, Montpetit A, Jokiaho A, Choi E, Asselta R, Bronnikov D, Lincoln MR, Sadovnick AD, Tienari PJ, Koivisto K, Palotie A, Ebers GC, Hudson TJ, Peltonen L.

PLoS Genet. 2006 Mar;2(3):e42. Epub 2006 Mar 31.

5.

Fine mapping of the multiple sclerosis susceptibility locus on 5p14-p12.

Riise Stensland HM, Saarela J, Bronnikov DO, Parkkonen M, Jokiaho AJ, Palotie A, Tienari PJ, Sumelahti ML, Elovaara I, Koivisto K, Pirttilä T, Reunanen M, Sobel E, Peltonen L.

J Neuroimmunol. 2005 Dec 30;170(1-2):122-33. Epub 2005 Sep 19.

PMID:
16169605
6.

No evidence for association of multiple sclerosis with the complement factors C6 and C7.

Chataway J, Sawcer S, Sherman D, Hobart M, Fernie B, Coraddu F, Feakes R, Broadley S, Gray J, Jones HB, Clayton D, Goodfellow PN, Compston A.

J Neuroimmunol. 1999 Sep 1;99(1):150-6.

PMID:
10496188
7.

DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.

Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F.

Hum Mol Genet. 1998 Aug;7(8):1235-7.

PMID:
9668164
8.

Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients.

Barcellos LF, Thomson G, Carrington M, Schafer J, Begovich AB, Lin P, Xu XH, Min BQ, Marti D, Klitz W.

JAMA. 1997 Oct 15;278(15):1256-61.

PMID:
9333267
9.

Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis.

Lin R, Charlesworth J, Stankovich J, Perreau VM, Brown MA; ANZgene Consortium., Taylor BV.

PLoS One. 2013;8(3):e56379. doi: 10.1371/journal.pone.0056379. Epub 2013 Mar 5.

10.

Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations.

Wu XM, Wang C, Zhang KN, Lin AY, Kira J, Hu GZ, Qu XH, Xiong YQ, Cao WF, Gong LY.

Mult Scler. 2009 Dec;15(12):1422-30. doi: 10.1177/1352458509345905. Epub 2009 Nov 13.

PMID:
19965521
11.

Golli-MBP gene in multiple sclerosis susceptibility.

Tienari PJ, Kuokkanen S, Pastinen T, Wikström J, Sajantila A, Sandberg-Wollheim M, Palo J, Peltonen L.

J Neuroimmunol. 1998 Jan;81(1-2):158-67.

PMID:
9521617
12.

Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia.

Marrosu MG, Murru R, Murru MR, Costa G, Zavattari P, Whalen M, Cocco E, Mancosu C, Schirru L, Solla E, Fadda E, Melis C, Porru I, Rolesu M, Cucca F.

Hum Mol Genet. 2001 Dec 1;10(25):2907-16.

PMID:
11741834
13.

Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.

Khankhanian P, Matsushita T, Madireddy L, Lizée A, Din L, Moré JM, Gourraud PA, Hauser SL, Baranzini SE, Oksenberg JR.

BMC Med Genet. 2015 Jul 28;16:55. doi: 10.1186/s12881-015-0201-2.

14.

Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Rubio JP, Bahlo M, Stankovich J, Burfoot RK, Johnson LJ, Huxtable S, Butzkueven H, Lin L, Taylor BV, Speed TP, Kilpatrick TJ, Mignot E, Foote SJ.

Immunogenetics. 2007 Mar;59(3):177-86. Epub 2007 Jan 26.

PMID:
17256150
15.

Decoding multiple sclerosis: an update on genomics and future directions.

Oksenberg JR.

Expert Rev Neurother. 2013 Dec;13(12 Suppl):11-9. doi: 10.1586/14737175.2013.865867. Review.

PMID:
24289837
16.
17.

The genetics of multiple sclerosis. A review.

Kalman B, Lublin FD.

Biomed Pharmacother. 1999 Sep;53(8):358-70. Review.

PMID:
10554670
18.

An NcoI polymorphism in the human complement component 7 (C7) gene.

Horiuchi T, Nishizaka H, Tsukamoto H, Harashima S, Sawabe T, Morita C, Niho Y.

J Hum Genet. 1999;44(4):270-1.

PMID:
10429371
19.

Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.

Cortes A, Field J, Glazov EA, Hadler J; ANZgene Consortium., Stankovich J, Brown MA.

Hum Mol Genet. 2013 Jun 1;22(11):2283-92. doi: 10.1093/hmg/ddt062. Epub 2013 Feb 12.

PMID:
23406874
20.

Linkage disequilibrium between the MBP tetranucleotide repeat and multiple sclerosis is restricted to a geographically defined subpopulation in Finland.

Pihlaja H, Rantamäki T, Wikström J, Sumelahti ML, Laaksonen M, Ilonen J, Ruutiainen J, Pirttilä T, Elovaara I, Reunanen M, Kuokkanen S, Peltonen L, Koivisto K, Tienari PJ.

Genes Immun. 2003 Mar;4(2):138-46.

PMID:
12618862

Supplemental Content

Support Center